期刊文献+

Danon病一例 被引量:3

原文传递
导出
摘要 Danon病是一种罕见的X连锁显性遗传的溶酶体贮积病,最早在1981年报道,在2000年确定其致病基因为溶酶体膜蛋白2 (LAMP-2)基因.Danon病以男性多见,肥厚型心肌病、骨骼肌病和智能障碍为其典型三联征.Danon病在国内报道较少,现报道1例无明显智能障碍的Danon病患者的临床、骨骼肌病理和遗传学特征.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2015年第10期895-897,共3页 Chinese Journal of Neurology
  • 相关文献

参考文献15

  • 1Danon MJ, Oh S J, Dimauro S, et al. Lysosomal glycogen storage disease with normal acid maltase[ J~. Neurology, 1981, 31 ( 1 ) : 51-57.
  • 2Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease) [J]. Nature, 2000, 406(6798): 906-910 .
  • 3Schorderet DF, Cottet S, Lobrinus JA, et al. Retinopathy in Danon disease[ J]. Arch Ophthalmol, 2007, 125 (2) : 231-236.
  • 4Tanaka Y, Guhde G, Suter A, et al. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice [ J ]. Nature, 2000, 406(6798): 902-906.
  • 5Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease [ J ]. Neurology, 2002, 58(12) : 1773-1778.
  • 6洪道俊,石志鸿,张巍,王朝霞,袁云.溶酶体相关膜蛋白2基因新突变导致Danon病的临床病理特点[J].中华神经科杂志,2010,43(10):707-711. 被引量:6
  • 7代英杰,陈琳,郭玉璞,关鸿志,刘智,任海涛,赵燕环,崔丽英.糖原累积病Ⅱ型20例临床及病理特点[J].中华神经科杂志,2011,44(2):91-95. 被引量:19
  • 8Yan C, Tanaka M, Sugie K, et al. A new congenital form of X- linked autophagic vacuolar myopathy [ J ]. Neurology, 2005, 65 (7) : 1132-1134.
  • 9Majer F, Pelak O, Kalina T, et al. Mosaic tissue distribution of the tandem duplication of LAMP2 exons 4 and 5 demonstrates the limits of Danon disease cellular and molecular diagnostics [ J ]. J Inherit Metab Dis, 2014, 37( 1 ) : 117-124.
  • 10Konecki DS, Foetisch K, Zimmer KP, et al. An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner [ J ]. Biochem Biophys Res Commun, 1995, 215(2) : 757-767.

二级参考文献37

  • 1陈琳,郭玉璞,任海涛,赵燕环,关鸿志,管宇宙,彭斌,刘大为.少年起病的Ⅱ型糖原累积病五例临床病理研究[J].中华神经科杂志,2005,38(1):51-54. 被引量:16
  • 2Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy ( Danon disease). Nature, 2000, 406:906-910.
  • 3Ruivo R, Anne C, Sagne C, et al. Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta, 2009, 1793:636-649.
  • 4Konecki DS, Foetisch K, Zimmer KP, et al. An alternatively spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner. Biochem Biophys Res Commun, 1995, 215:757-767.
  • 5Maron B J, Roberts WC, Arad M, et al. Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy. JAMA, 2009, 301 : 1253-1259.
  • 6Sabourdy F, Michelakakis H, Anastasakis A, et al. Danon disease: further clinical and molecular heterogeneity. Muscle Nerve, 2009, 39:837-844.
  • 7Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology, 2002, 58 : 1773-1778.
  • 8Lobrinus JA, Schorderet DF, Payot M, et al. Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease). Neuromuscul Disord, 2005, 15:293- 298.
  • 9Schorderet DF, Cottet S, Lobrinus JA, et al. Retinopathy in Danon disease. Arch Ophthalmol, 2007, 125:231-236.
  • 10Tunon T, Guerrero D, Urchaga A, et al. Danon disease: a novel Lamp-2 gene mutation in a family with four affected members. Neuromuscul Disord, 2008, 18 : 167-174.

共引文献22

同被引文献4

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部